We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -0.14% | 35.15 | 35.15 | 35.40 | 36.30 | 35.00 | 35.50 | 2,407,899 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 207.06 | 190.13M |
TIDMAPH
RNS Number : 5907E
Alliance Pharma PLC
11 April 2014
For immediate release 11 April 2014
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Major Interest in Shares
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was informed on 10 April 2014 that on 9 April 2014, Nigel Wray purchased 1,550,000 ordinary shares of 1p each in the Company.
Mr Wray's resultant holding is 39,656,995 ordinary shares, equivalent to 15.02% of the Company's issued share capital.
Mr Wray's Ordinary Shares are held as follows:
Nominee Number of ordinary shares Pershing Nominees Limited 14,992,407 Roy Nominees Limited 24,664,588 --------------------------
For further information:
Alliance Pharma plc + 44 (0) 1249 466966 John Dawson, Chief Executive Richard Wright, Finance Director Buchanan + 44 (0) 20 7466 5000 Mark Court / Fiona Henson / Sophie Cowles Numis Securities Limited + 44 (0) 20 7260 1000 Nominated Adviser: Michael Meade / Oliver Cardigan Corporate Broking: David Poutney
Notes to editors:
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLSFSFMSFLSELL
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions